Adequan is an FDA-approved injectable drug primarily utilized for treating arthritis in dogs. It is considered a disease-modifying osteoarthritis drug (DMOAD). Unlike traditional pain relievers that ...

As reported on News Center 7 Daybreak, pet parents say their vets never warned them about the side effects and want answers. Our sister station WSB in Atlanta reports that the FDA is “looking at ...

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions. By Emily Anthes A popular drug for dogs with arthritis may be associated ...

Dog owners will go to great lengths to keep their beloved pets safe and healthy, including getting them the medicines they need. But just as with human medications, issues can arise with the very ...

The Food and Drug Administration is warning veterinarians about deaths, debilitating neurological issues and other side effects that followed use of a popular arthritis drug for dogs. The agency said, ...

In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela. The drug's maker, however, claims that it remains safe and effective. reading ...

A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including seizures and a loss of muscle control, according to a recent review by the ...